Pharvaris (PHVS) Reports an 83% HAE Attack-Rate Reduction. Can Oral Convenience Win?
Pharvaris N.V.
Pharvaris N.v. (PHVS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 3,653,310 | $126,331,460 | 0.36% | |
| 2. | Deerfield Management James E. Flynn | 3,376,042 | $116,743,532 | +8% | 1.22% |
| 3. | Polar Capital Brian Ashford-Russell And Tim Woolley | 2,326,389 | $80,446,532 | +198% | 0.19% |
| 4. | Point72 Asset Management Steve Cohen | 1,641,200 | $56,752,696 | +63% | 0.06% |
| 5. | Commodore Capital Egen Atkinson And Michael Kramarz | 1,425,000 | $49,276,500 | -26% | 2.93% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.05 | 11,969 | $395,523.98 | 5,500 | 2026-09-23 | Filing | |
| $36.19 | 800 | $28,952.00 | 115,167 | 2026-09-22 | Filing | |
| $36.47 | 6,000 | $218,800.80 | 114,300 | 2026-09-21 | Filing | |
| $35.00 | 100,000 | $3,500,000.00 | 64,953 | 2026-09-17 | Filing | |
| $35.00 | 200,000 | $7,000,000.00 | 115,167 | 2026-09-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,565,272 | $227,027,106 | 0.01% | |
| 2. | 6,550,757 | $226,525,177 | 7.79% | |
| 3. | 4,778,581 | $165,243,331 | 56.95% | |
| 4. | 4,643,430 | $160,569,809 | 30.92% | |
| 5. | 3,424,609 | $118,422,979 | 13.73% |
News See All
What Does Wall Street Think About Pharvaris N.V. (PHVS)?
Pharvaris N.V. (NASDAQ:PHVS) is one of the best small cap stocks to buy with huge upside potential. Morgan Stanley analyst Maxwell Skor reiterated a Buy rating on Pharvaris N.V.
12 Small Cap Stocks to Buy with Huge Upside Potential
In ths article, we will look at the 12 Small Cap Stocks to Buy with Huge Upside Potential.
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on its optimism about the company's prophylactic treatment for Hereditary Angioedema...
Billionaire Andreas Halvorsen's Top 15 Long-Term Stock Picks
In this article, we discuss the top 15 long-term stock picks of billionaire Andreas Halvorsen.
7 Best Stocks Under $20 According to Billionaire Andreas Halvorsen's Viking Global
In this article, we take a look at the 7 best stocks under $20 according to billionaire Andreas Halvorsen's Viking Global.
Hedge Fund Resource Center